.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Dow
QuintilesIMS
Cipla
Merck
Mallinckrodt
Deloitte
Novartis
McKinsey
Healthtrust

Generated: June 24, 2017

DrugPatentWatch Database Preview

POTASSIUM CITRATE Drug Profile

« Back to Dashboard

Which patents cover Potassium Citrate, and what generic Potassium Citrate alternatives are available?

Potassium Citrate is a drug marketed by Impax Labs Inc, Zydus Pharms Usa Inc, and Ut Sw Medctr. and is included in three NDAs.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and twenty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

Summary for Tradename: POTASSIUM CITRATE

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list33
Clinical Trials: see list1,072
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:POTASSIUM CITRATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
POTASSIUM CITRATE
potassium citrate
TABLET, EXTENDED RELEASE;ORAL077440-001Jun 9, 2006ABRXNoNo► Subscribe► Subscribe
Ut Sw Medctr
POTASSIUM CITRATE
potassium citrate
FOR SOLUTION;ORAL019647-001Oct 13, 1988DISCNYesNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
POTASSIUM CITRATE
potassium citrate
TABLET, EXTENDED RELEASE;ORAL203546-002Aug 6, 2014ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
POTASSIUM CITRATE
potassium citrate
TABLET, EXTENDED RELEASE;ORAL077440-002Jun 9, 2006ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
POTASSIUM CITRATE
potassium citrate
TABLET, EXTENDED RELEASE;ORAL203546-001Aug 6, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Mallinckrodt
Harvard Business School
Colorcon
Fuji
Argus Health
Cantor Fitzgerald
Moodys
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot